Ben Chiarelli

Founder & CEO, Cellibre

Ben is the founder and CEO of Cellibre, a next-generation biotechnology company that is ushering in the next great industrial revolution by treating biology as a manufacturing technology, turning cells into specialized, sustainable factories for the manufacture of globally significant products at scale.

Ben formally worked with Dr. J Craig Venter and Nobel Laureate Dr. Ham Smith as the Vice President of Corporate Development and Strategy at Synthetic Genomics (SGI) where he was responsible for defining, evolving and implementing SGI’s strategy across all of its franchises.

Ben joined SGI from Millennium Health, a leading medication solutions company focused on solving the opioid epidemic, where he led the strategy and corporate development efforts. Prior to joining industry, Ben had a nine-year tenure on Wall Street, where he executed over $20 billion in transactions.

Ben earned his MBA from Carnegie Mellon University’s Tepper School of Business and his B.S. in Mechanical Engineering from Case Western Reserve University. He is also the co-founder of Divitempus Ventures, ConvenCare and the 32/21 Foundation.

Matthew Greene

New York, NY, USA
CEO & Founder, Edible Science, LLC

Matt Greene has spent his entire career in the marketing, advertising and AdTech industry. His fascination with technology began in 1987 while working with his client Steve Jobs in developing the launch strategies for NeXT Computers. Starting in 1998, Matt pioneered online advertising and supporting technologies for the digital ad agency he founded, Blue Ribbon Digital, where his team drove innovation across all aspects of digital media - from Search to Mobile and Video, his agency measurably generated over $2BB in revenues for their Fortune 100 clients. In this capacity, Matt has spoken at leading conferences such as AdTech, iMedia Summits and the Googleplex in Mountain View, CA. Starting in 2015, Matt re-focused his energies on the burgeoning cannabis industry knowing that the need for innovation in technologies to support the industry would be mandatory. With his his new company, Edible Sciences, he and his team on concentrating their energies in solving the #1 problem facing the edibles sector: Dosing Accuracy. He will be speaking at Binghampton University's TIER Talks in SEPT '17 on technology innovations occurring in the cannabis ancillary space.
Close

Brett Finkelstein

Boca Raton, FL
Managing Director, Phyto Partners LP

Brett is an experienced executive, venture capital and private equity investor and advisor. He has partnered with, worked with and developed key relationships with numerous premier private equity, investment banks, and venture capital companies. As one of the founders of Phyto Partners LP, Brett’s fundamental ambition for the company’s stakeholders is to creatively apply his unique resources of extensive operating skills, certainty to close, access to capital, extensive network of resources and relentless pursuit of excellence to facilitate a more super-charged evolution for enterprises we fund, launch, and maintain activist roles in. For the powerhouse companies we invest in, advise, and or buy we will be providing more investment value and a comfort level for our financial capital partners, as well as our portfolio companies that join us. Phyto Partners LP was profiled in Forbes as one of the leaders in the cannabis industry. Phyto has invested in half of what CB insights profiled as the trailblazers of 2017. 
Close